Literature DB >> 5420622

Reduction of serum cholesterol and triglyceride levels by the combined administration of neomycin and clofibrate.

P Samuel, C M Holtzman, E Meilman, I Sekowski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5420622     DOI: 10.1161/01.cir.41.1.109

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

Review 1.  A comparative review of the adverse effects of treatments for hyperlipidaemia.

Authors:  A Steiner; B Weisser; W Vetter
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

Review 2.  Lipid lowering drugs and hyperlipidaemia.

Authors:  R I Levy; B M Rifking
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 3.  Hypolipaemic drugs and coronary heart disease.

Authors:  A N Howard
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

4.  [Drug treatment of primary hyperlipoproteinemia (author's transl)].

Authors:  G Klose; R Mordasini; G Middelhoff; J Augustin; H Greten
Journal:  Klin Wochenschr       Date:  1978-02-01

5.  Effect of neomycin sulphate alone and in combination with D-thyroxine on serum lipoproteins in hypercholesterolaemic subjects.

Authors:  K H Vogelberg; T Koschinsky; H Hein; F A Gries
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Long-term kinetics of serum and xanthoma cholesterol radioactivity in patients with hypercholesterolemia.

Authors:  P Samuel; W Perl; C M Holtzman; N D Rochman; S Lieberman
Journal:  J Clin Invest       Date:  1972-02       Impact factor: 14.808

Review 7.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb

8.  Cholesterol malabsorption caused by sitostanol ester feeding and neomycin in pravastatin-treated hypercholesterolaemic patients.

Authors:  H Vanhanen
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

9.  Action of neomycin on the intraluminal phase of lipid absorption.

Authors:  G R Thompson; J Barrowman; L Gutierrez; R H Dowling
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.